Impel Pharmaceuticals Inc's ROI from its third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Impel Pharmaceuticals Inc's ROI in the third quarter of 2023?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Impel Pharmaceuticals Inc 's return on investment (ROI) in its third quarter of 2023

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter
Y / Y Investment Change TTM	-	-71.52 %	-20.19 %	53.87 %	137.73 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	-90	-76	42	66	85
Return On Investment (TTM)	-	-	-147.76 %	-112.63 %	-109.9 %
IMPL's Overall Ranking	# 4603	# 4365	# 3811	# 4417	# 0
Seq. Investment Change TTM	-	-60.28 %	-21.55 %	-3.96 %	-4.83 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-74	-92	-109	-106	-108

IMPL Company Profile >> Back to IMPL Roi Comparisons >> See Annual IMPL Return On Investment

Return On Investment IMPL's Ranking
Within:	No.
Industry	# 453
Sector	# 940
Overall	# 4603

Return On Investment Statistics
High	Average	Low
-71.99 %	-135.98 %	-438.02 %
(Dec 31 2022)		(Sep 30 2023)

Financial Statements
Impel Pharmaceuticals Inc's III. Quarter Investments	$ -90 Millions	IMPL's Balance sheet
Impel Pharmaceuticals Inc's III. Quarter Income	$ -14 Millions	Quarterly IMPL's Income Statement
IMPL's Income by Division		See IMPL's Income by Division

IMPL Annual Return On Investment	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	66	82	0	0	0
Y / Y Investment Growth	-19 %	-	-	-	-
Net Income in Millions	-106	-77	0	0	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-160.14 %	-93.38 %	-	-	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
IMPL's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for IMPL's Competitors
Subscribers only: Roi for Impel Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for IMPL's Customers

Other Ratios
IMPL's Roa	IMPL's Inventory Turnover Ratio	IMPL's Growth Rates	IMPL's Dividend Statistics
	IMPL's Profitability Ratios	IMPL's Asset Turnover Ratio	IMPL's Dividend Growth
IMPL's Roe	IMPL's Valuation Ratios	IMPL's Financial Strength Ratios	IMPL's Dividend Payout Ratio

Companies with similar Return On Investment at Sep 30 2023, within Healthcare Sector	ROI
Ir med Inc	300.96 %
Tff Pharmaceuticals Inc	241.72 %
Therapeuticsmd Inc	179.97 %

Date modified: 2026-09-08T15:11:07+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.